DEFERASIROX (DEFERASIROX) — FDA Approval ANDA207124 (TEVA PHARMS USA)
DEFERASIROX (DEFERASIROX) — FDA Approval ANDA207124 (TEVA PHARMS USA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: DEFERASIROX; Active ingredients: DEFERASIROX; Application number: ANDA207124.
| Brand name | DEFERASIROX |
|---|---|
| Active ingredients | DEFERASIROX |
| Application number | ANDA207124 |
| Sponsor | TEVA PHARMS USA |
| Dosage form | TABLET, FOR SUSPENSION |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 3 |
| First approval date | 20220923 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →